LipoTrue’s Munapsys™ awarded with BSB Innovation Award

LipoTrue has received the 2019 BSB Innovation First Prize for Munapsys™ for the Most Innovative Raw Material in the cosmetic Active’s category this past April by the independent BSB – Beratungs- and Servicebuero Dr. Riedel e.K. (Dr. Riedel Consulting Services Agency).
Nowadays, in the cosmetic market there are ingredients acting in the pre-synaptic pathway or in the post-synaptic one. Munapsys™ is more than a botulinum-toxin like peptide being the first active ingredient in the cosmetic industry to act both in the pre- and post-synaptic pathways in muscle contraction and in a new protein (munc-18) key for the assembly of the SNARE complex. Munapsys™ mechanism is a real upgrade in the expression lines field with proven outstanding efficacy compared with a benchmark combination even at a lower dose.
The BSB Innovation Award was presented to LipoTrue on April 2, 2019, during in-cosmetics Global in Paris.

About BSB Innovation Award®

The BSB Innovation Prize has been awarded annually by Beratungs- und Servicebüro Dr. Riedel (Dr. Riedel Consulting Services Agency). The winners are selected by an independent, international jury consisting of prestigious representatives of the cosmetics industry.
About LipoTrue
LipoTrue acts as a central R&D engine, integrating different technology platforms such as the production of synthetic proteins in plants, in silico & biomimetic peptide design, and marine bio-research of new microorganisms with unique efficacies. LipoTrue characterizes these active ingredients, and analyzes the Big Data obtained to transform it into Smart Data. LipoTrue also has the ability to incorporate new platforms quickly and efficiently as new market demands emerge. LipoTrue invites you to discover more at www.lipotrue.com.
For more information, please click here.

Leave a Comment